Glyxambi
8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione;(2S,3R,4R,5S,6S)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-methoxyoxane-3,4,5-triol
Molecular Identity
Glyxambi
8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione;(2S,3R,4R,5S,6S)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-methoxyoxane-3,4,5-triol
PubChem CID: 85364159
2D Structure
Properties
C48H55ClN8O9
Molecular Formula
923.40
Molecular Weight
g/mol
922.3781
Exact Mass
Da
211
TPSA
May have limited oral absorption
4
H-Bond Donors
14
H-Bond Acceptors
1440
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(15)
GlyxambiEmpagliflozin/linagliptinRefChem:65762Empagliflozin-LinagliptinEmpagliflozin; LinagliptinLINAGLIPTIN/EMPAGLIFLOZINLINAGLIPTIN;EMPAGLIFLOZINLINAGLIPTIN / EMPAGLIFLOZINEmpagliflozin/Linagliptin Combination AgentEmpagliflozin / LinagliptinEmpagliflozin and LinagliptinLinagliptin and EmpagliflozinSCHEMBL29396827DTXSID901336126S900006430
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Glyxambi
Loading drug network...